Page last updated: 2024-11-08

naphthalan

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

naphthalan: oil containing naphthalanic hydrocarbons, nitric & other cpds [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID588214
SCHEMBL ID5093529
MeSH IDM0128578

Synonyms (11)

Synonym
1H,3H-BENZO[DE]ISOCHROMENE ,
1h,3h-naphtho[1,8-cd]pyran
naphthalan
37229-16-6
naphthalan (ointment)
SCHEMBL5093529
3h-benzo[de]isochromene
2,1,3-peri-naphthopyran
1h,3h-benzo[de]isochromene #
DTXSID90958400
3-oxatricyclo[7.3.1.05,13]trideca-1(12),5,7,9(13),10-pentaene

Research Excerpts

Effects

ExcerptReferenceRelevance
"Naphthalan has long been known for its medicinal properties and beneficial effect in inflammatory diseases such as psoriasis, atopic dermatitis, and psoriatic dermatitis. "( Naphthalan--a natural medicinal product.
Alajbeg, A; Ostrogović, Z; Vrzogić, P, 2003
)
3.2
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (20)

TimeframeStudies, This Drug (%)All Drugs %
pre-199012 (60.00)18.7374
1990's1 (5.00)18.2507
2000's4 (20.00)29.6817
2010's1 (5.00)24.3611
2020's2 (10.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 89.95

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index89.95 (24.57)
Research Supply Index3.87 (2.92)
Research Growth Index4.84 (4.65)
Search Engine Demand Index157.97 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (89.95)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials6 (14.63%)5.53%
Reviews1 (2.44%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other34 (82.93%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]